The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Caspase‐3 regulates the migration, invasion and metastasis of colon cancer cells
Open accessAbstract
Caspase‐3 (CASP3) is a major mediator of apoptosis activated during cellular exposure to cytotoxic drugs, radiotherapy or immunotherapy. It is often used as a marker for efficacy of cancer therapy. However, recent reports indicate that caspase‐3 has also non‐apoptotic roles such as promotion of tumor relapse and tumor angiogenesis. Therefore, the roles of caspase‐3 in tumor progression remain to be defined clearly. In our study, we established caspase‐3 knockout (KO) colon cancer cell lines by use of the CRISPR technology. In vitro, caspase‐3 knockout HCT116 cells were significantly less clonogenic in soft agar assays. They were also significantly less invasive and more sensitive to radiation and mitomycin C than control cells. In vivo, CASP3KO cells formed tumors at rates similar to control cells but were significantly more sensitive to radiotherapy. They were also less prone to pulmonary metastasis when inoculated either subcutaneously or intravenously. At the mechanistic level, caspase‐3 gene knockout appeared to cause reduced EMT phenotypes when compared to parental HCT116 cells. Indeed, they showed significantly increased E‐cadherin expression, reduced N‐cadherin, Snail, Slug and ZEB1 expression than control cells. Therefore, therapeutic targeting of caspase‐3 may not only increase the sensitivity of cancer cell to chemotherapy and radiotherapy, but also inhibit cancer cell invasion and metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Liang, C.-C., Park, A. Y., & Guan, J.-L. (2007) · Nature Protocols · doi:10.1038/nprot.2007.30 · Cited by 4,696
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L. A., Knuechel, R., & Kirchner, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171610498 · Cited by 1,049
Lauber, K., Bohn, E., Kröber, S. M., Xiao, Y.-J., Blumenthal, S. G., Lindemann, R. K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00422-7 · Cited by 967
Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy
Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F.-F., O'Sullivan, B., He, Z., Peng, Y., Tan, A.-C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2385 · Cited by 886
Self-citationApoptosis, p53, and tumor cell sensitivity to anticancer agents.
Brown, J. M., & Wouters, B. G. (1999) · PubMed · Cited by 696
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
Kurtova, A. V., Xiao, J., Mo, Q., Pazhanisamy, S., Krasnow, R., Lerner, S. P., Chen, F., Roh, T. T., Lay, E., Ho, P. L., et al. (2015) · Nature · doi:10.1038/nature14034 · Cited by 578
Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes
Berger, A. C., Sigurdson, E. R., LeVoyer, T., Hanlon, A., Mayer, R. J., Macdonald, J. S., Catalano, P. J., & Haller, D. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8852 · Cited by 518
Caspases Connect Cell-Death Signaling to Organismal Homeostasis
Galluzzi, L., López-Soto, A., Kumar, S., & Kroemer, G. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.020 · Cited by 350
Manfredi, S., Bouvier, A. M., Lepage, C., Hatem, C., Dancourt, V, & Faivre, J. (2006) · British Journal of Surgery · doi:10.1002/bjs.5349 · Cited by 320
Caspase-3 Promotes Genetic Instability and Carcinogenesis
Liu, X., He, Y., Li, F., Huang, Q., Kato, T. A., Hall, R. P., & Li, C.-Y. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.003 · Cited by 263
Self-citationPattern of distant metastases in colorectal cancer: a SEER based study
Qiu, M., Hu, J., Yang, D., Cosgrove, D. P., & Xu, R. (2015) · Oncotarget · doi:10.18632/oncotarget.6130 · Cited by 249
Cifone, M. A., & Fidler, I. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.1039 · Cited by 243
IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment
Fang, M., Li, Y., Huang, K., Qi, S., Zhang, J., Zgodzinski, W., Majewski, M., Wallner, G., Gozdz, S., Macek, P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1602 · Cited by 187
Xiao, F., Yu, Y., He, S., Cheng, J. Q., Gong, Y., Zhang, Z., Yang, X., Xu, B., Liu, X., Li, C., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.042 · Cited by 158
Self-citationCaspase 2 and Caspase 3 Protein Levels as Predictors of Survival in Acute Myelogenous Leukemia
Estrov, Z. E., Thall, P. F., Talpaz, M., Estey, E. H., Kantarjian, H. M., Andreeff, M., Harris, D., Van, Q., Walterscheid, M., & Kornblau, S. M. (1998) · Blood · doi:10.1182/blood.v92.9.3090 · Cited by 156
Zhao, X., Wang, D., Zhao, Z., Xiao, Y.-Y., Sengupta, S., Xiao, Y., Zhang, R., Lauber, K., Wesselborg, S., Feng, L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513105200 · Cited by 138
The role of the EP receptors for prostaglandin E2 in skin and skin cancer
Rundhaug, J. E., Simper, M., Surh, I., & Fischer, S. M. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9317-9 · Cited by 115
Flanagan, L., Meyer, M. S., Fay, J., Curry, S., Bacon, O., Düßmann, H., John, K., Boland, K., McNamara, D. A., Kay, E. W., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.7 · Cited by 115
Caspase 3 Promotes Surviving Melanoma Tumor Cell Growth after Cytotoxic Therapy
Donato, A. L., Huang, Q., Liu, X., Li, F., Zimmerman, M. A., & Li, C. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.18 · Cited by 113
Self-citationIdentification and Characterization of a Novel Mammalian Caspase with Proapoptotic Activity
Eckhart, L., Ballaun, C., Uthman, A., Kittel, C., Stichenwirth, M., Buchberger, M., Fischer, H., Sipos, W., & Tschachler, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500282200 · Cited by 78
Hypoxia-Induced Downregulation of DUSP-2 Phosphatase Drives Colon Cancer Stemness
Hou, P., Li, Y.-H., Lin, S., Lin, S.-C., Lee, J., Lin, B.-W., Liou, J., Chang, J., Kuo, C., Liu, Y.-M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2990 · Cited by 71
Cross Talk between Apoptosis and Invasion Signaling in Cancer Cells through Caspase-3 Activation
Mukai, M., Kusama, T., Hamanaka, Y., Koga, T., Endo, H., Tatsuta, M., & Inoue, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4344 · Cited by 53
Can metastatic colorectal cancer be cured?
Bartlett, D. L., & Chu, E. (2012) · PubMed · Cited by 35
Cited by
Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis
(2021) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2021.01.003 · Cited by 402
Targeting apoptotic caspases in cancer
Boice, A., & Bouchier-Hayes, L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118688 · Cited by 391
A Systematic Pan-Cancer Analysis of CASP3 as a Potential Target for Immunotherapy
Zhou, Z., Xu, S., Jiang, L., Tan, Z., & Wang, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.776808 · Cited by 36
Zhang, C., Yang, X., Fu, C., & Liu, X. (2018) · Gene · doi:10.1016/j.gene.2018.06.030 · Cited by 30
Self-citation
Metadata
- Authors
- Zhou, M., Liu, X., Li, Z., Huang, Q., Li, F., & Li, C.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2018-03-30
- Volume
- 143
- Issue
- 4
- Pages
- 921-930
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2790216110
- Cited by
- 302
- References
- 26
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.